Abiopharma

🔍 Settlement 1740 Trust #33 (Executive)

Company: Hyatt Hotels Corp (H)

Report Date: 2026-04-16

Detailed Transactions and Holdings:

• Sold 8,970 shares of Class B Common Stock (Derivative)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1

Footnotes:

• F1: As provided in the Issuer's Amended and Restated Certificate of Incorporation, each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon any transfer, whether or not for value, except for certain permitted transfers described in the Issuer's Amended and Restated Certificate of Incorporation.
• F2: Represents the weighted average sale price. The highest price at which shares were sold was $163.53 and the lowest price at which shares were sold was $163.50. The reporting person undertakes to provide to Hyatt Hotels Corporation, any security holder of Hyatt Hotels Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
• REMARKS: The Reporting Person may be deemed to be a member of a 10% owner group because the Reporting Person has agreed to certain voting agreements and limitations on transfers of shares of Class A Common Stock and Class B Common Stock. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of the pecuniary interest therein.